View Profile

Anas Al Zabiby

Real World Evidence Bioinformatics · Novartis

https://researchid.co/alzabiby.anas
@novartis.com
37Google Scholar Citations
2Google Scholar h-index
1Google Scholar i10-index

Recent Google Scholar Publications

  1. Review of current clinical strategies of managing patients with elevated lipoprotein (a): cost-effectiveness of Lp (a) testing and patient awareness of lifestyle changes …
    Heart, Lung and Circulation 33, S534 , 2024, 2024 | Citations: 2.0
  2. The Risk of MACE Associated With Elevated Lp (a) in a Primary Prevention Population
    Heart, Lung and Circulation 33, S541 , 2024, 2024
  3. Elevated lipoprotein (a) increases risk of subsequent major adverse cardiovascular events (MACE) and coronary revascularisation in incident ASCVD patients: a cohort study from …
    Atherosclerosis 389, 117437 , 2024, 2024 | Citations: 31.0
  4. EPH58 The Risk of First and Recurrent Mace Associated with Elevated Lp (A) in a Primary Prevention Population
    Value in Health 26 (12), S213 , 2023, 2023
  5. Increased Risk of Major Adverse Cardiovascular Events Attributed to Lipoprotein (a) Across Current Atherosclerotic Cardiovascular Disease Risk Categories
    Circulation 148 (Suppl_1), A14601-A14601 , 2023, 2023

Links